QQQ   423.38 (-0.58%)
AAPL   167.06 (-0.56%)
MSFT   404.45 (-1.79%)
META   502.07 (+1.60%)
GOOGL   156.06 (+0.38%)
AMZN   179.22 (-1.14%)
TSLA   150.12 (-3.43%)
NVDA   846.88 (+0.78%)
AMD   155.11 (+0.71%)
NIO   4.00 (+2.30%)
BABA   68.89 (+0.10%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   153.06 (-1.68%)
CGC   7.84 (+20.80%)
DIS   112.51 (-0.38%)
AMC   2.93 (-1.68%)
PFE   25.38 (-0.16%)
PYPL   62.13 (-1.79%)
XOM   118.60 (-0.03%)
QQQ   423.38 (-0.58%)
AAPL   167.06 (-0.56%)
MSFT   404.45 (-1.79%)
META   502.07 (+1.60%)
GOOGL   156.06 (+0.38%)
AMZN   179.22 (-1.14%)
TSLA   150.12 (-3.43%)
NVDA   846.88 (+0.78%)
AMD   155.11 (+0.71%)
NIO   4.00 (+2.30%)
BABA   68.89 (+0.10%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   153.06 (-1.68%)
CGC   7.84 (+20.80%)
DIS   112.51 (-0.38%)
AMC   2.93 (-1.68%)
PFE   25.38 (-0.16%)
PYPL   62.13 (-1.79%)
XOM   118.60 (-0.03%)
QQQ   423.38 (-0.58%)
AAPL   167.06 (-0.56%)
MSFT   404.45 (-1.79%)
META   502.07 (+1.60%)
GOOGL   156.06 (+0.38%)
AMZN   179.22 (-1.14%)
TSLA   150.12 (-3.43%)
NVDA   846.88 (+0.78%)
AMD   155.11 (+0.71%)
NIO   4.00 (+2.30%)
BABA   68.89 (+0.10%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   153.06 (-1.68%)
CGC   7.84 (+20.80%)
DIS   112.51 (-0.38%)
AMC   2.93 (-1.68%)
PFE   25.38 (-0.16%)
PYPL   62.13 (-1.79%)
XOM   118.60 (-0.03%)
QQQ   423.38 (-0.58%)
AAPL   167.06 (-0.56%)
MSFT   404.45 (-1.79%)
META   502.07 (+1.60%)
GOOGL   156.06 (+0.38%)
AMZN   179.22 (-1.14%)
TSLA   150.12 (-3.43%)
NVDA   846.88 (+0.78%)
AMD   155.11 (+0.71%)
NIO   4.00 (+2.30%)
BABA   68.89 (+0.10%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   153.06 (-1.68%)
CGC   7.84 (+20.80%)
DIS   112.51 (-0.38%)
AMC   2.93 (-1.68%)
PFE   25.38 (-0.16%)
PYPL   62.13 (-1.79%)
XOM   118.60 (-0.03%)
Free Trial

INmune Bio (INMB) Earnings Date, Estimates & Call Transcripts

→ Nvidia Has a BIG Problem — Here’s Who Benefits MOST (From Weiss Ratings) (Ad)
Free INMB Stock Alerts
$8.79
+0.36 (+4.27%)
(As of 03:57 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

INMB Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

INMB Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

INMB Earnings Date and Information

INmune Bio has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 1st, 2024 based off prior year's report dates.

INmune Bio Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/1/2024
Estimated)		------- 
11/1/2023Q3 2023-($0.48)($0.48)($0.48)-$0.04 million
8/7/2023Q2 2023-($0.36)($0.36)($0.36)-$0.05 million
5/3/2023Q1 2023-($0.36)($0.36)($0.36)-$0.04 million
3/2/2023Q4 2022-($0.32)($0.32)($0.32)-$0.10 million
11/2/2022Q3 2022($0.59)($0.43)+$0.16($0.43)-$0.10 million
8/3/2022Q2 2022($0.50)($0.38)+$0.12($0.38)-$0.02 million    
5/5/2022Q1 2022($0.60)($0.39)+$0.21($0.39)-$0.16 million    
3/3/2022Q4 2021($0.56)($0.55)+$0.01($0.55)-$0.16 million    
11/2/2021Q3 2021($0.43)($0.55)($0.12)($0.55)-$0.01 million    
8/3/2021Q2 2021($0.34)($0.44)($0.10)($0.44)--  
5/4/2021Q1 2021($0.27)($0.32)($0.05)($0.32)--  

INmune Bio Earnings - Frequently Asked Questions

When is INmune Bio's earnings date?

INmune Bio has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 1st, 2024 based off last year's report dates. Learn more on INMB's earnings history.

How much revenue does INmune Bio generate each year?

INmune Bio (NASDAQ:INMB) has a recorded annual revenue of $160,000.00.

How much profit does INmune Bio generate each year?

INmune Bio (NASDAQ:INMB) has a recorded net income of -$30.01 million. INMB has generated -$1.67 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:INMB) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
[Urgent!] Generational Wealth Gameplan
Crypto 101 Media
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
He Is Giving Away Bitcoin
Crypto Swap Profits
Your Money is Not Safe
American Alternative